Showing results (1081-1090 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|February 5, 2014
Antigen-specific therapy against type 1 diabetes: mechanisms and perspectivesXiaoxiao Wan, Habib Zaghouani
Immunotherapy|February 5, 2014
Immunosuppression following heart transplantation: prospects and challengesDavid H Chang, Michelle M Kittleson, Jon A Kobashigawa
Immunotherapy|February 3, 2025
Exploring the role of immunotherapy in the management of follicular cell-derived thyroid cancerPaige Benson, Omar Abdel-Rahman
Immunotherapy|January 9, 2025
Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II)Stanley Szefler, Jonathan Corren, Jonathan I Silverberg, et al.
Immunotherapy|April 4, 2025
Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitorsXiao Hu, Angie Mae Rodday, Anastasia Gurinovich, et al.
Immunotherapy|November 18, 2024
Cost-effectiveness of Upadacitinib vs. Tofacitinib for moderate-to-severe rheumatoid arthritis in ChinaXinyi Xu, Linyu Geng, Xue Xu, et al.
Immunotherapy|October 11, 2024
Impact of immune-related adverse events on survival among patients with head-and-neck squamous cell carcinomaOmar Elghawy, Adam Barsouk, Reema Patel, et al.
Immunotherapy|September 26, 2024
Immunoglobulin therapies for primary immunodeficiency diseases (part 1): understanding the pharmacokineticsIftekhar Mahmood, Zhaoyang Li
Immunotherapy|September 11, 2024
Neoadjuvant envafolimab in a patient with MSI-H/dMMR colon cancer: a case report and literature reviewZiwei Chen, Jingrui Zhou, Weimin Chen, et al.
Immunotherapy|September 11, 2024
Cost-effectiveness analysis of immune checkpoint inhibitors as first-line therapy in advanced biliary tract cancerRuizhe Liu, Yijia Zhao, Fenghao Shi, et al.
Pageof 188